DEA
Articles tagged with “DEA”
The Ryan Haight Act and Telehealth Ketamine: History, Exemptions, and Ongoing Debate
The history of the Ryan Haight Act, how it affected telehealth ketamine prescribing, what COVID exemptions changed, and where the debate stands today.
The Future of Telehealth Ketamine Regulations: DEA Rules, SUPPORT Act, and Beyond
What the future regulatory landscape for telehealth ketamine looks like—DEA permanent rules, Congressional activity, and how the framework may evolve through 2026 and beyond.
2025 Telehealth Ketamine Laws: What Changed and What to Watch
Key regulatory changes affecting telehealth ketamine in 2025—DEA extension updates, state law changes, and the evolving permanent telemedicine prescribing framework.
DEA Compliance for Telehealth Ketamine Prescribing
How telehealth ketamine providers comply with DEA regulations, including Ryan Haight Act exemptions, special registration proposals, and controlled substance prescribing rules.
Ketamine Telehealth Laws by State: Where It's Legal and How Rules Differ (2025)
Which states allow telehealth ketamine prescribing? Covers the Ryan Haight Act, DEA rules, NP prescribing authority, and which states are easiest for getting started.
DEA Regulations for Telehealth Ketamine: Schedule III Rules, Ryan Haight, and Exemptions
A deep dive into DEA regulations governing telehealth ketamine prescribing—Schedule III rules, the Ryan Haight Act, COVID exemptions, and the proposed special registration framework.
Have a question about this topic?
Use the contact page when you need to send feedback, request a correction, or ask about the resource.